Highlights from ESMO 2020 Virtual

touchPODCAST
14/01/2021 1h 3min Episodio 1
Highlights from ESMO 2020 Virtual

Listen "Highlights from ESMO 2020 Virtual"

Descargar episodio Ver en sitio original

Episode Synopsis

touchCONGRESS for touchONCOLOGY
Listen to key highlights from ESMO Virtual 2020. This touchPODCAST is presented by Dr Catherine Kelly. 
We specifically focus on data presented at this congress describing CDK4/6 inhibitors in HR+/HER2- breast cancer and what these data could mean for clinical practice. 
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Eli Lilly. This activity is provided by touchIME.
For further information visit our website: https://touchoncologyime.org/hrher2-breastcanceresmo2020touchcongress/

More episodes of the podcast touchPODCAST

Managing cytopenias: The path to transfusion independence for patients with myelofibrosis 05/12/2025
Innovations and advances in CML: Focus on navigating early-line options and maintaining quality of life 20/11/2025
Breakthroughs in treating NSCLC: Targeting KRAS 19/11/2025
HER2 in focus: Advancing treatment for biliary tract and gastroesophageal cancers 18/11/2025
Delivering state-of-the-art care for GEP-NETs: Evidence-based strategies for PRRT 18/11/2025
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC 17/11/2025
Eyeing better outcomes in diabetic macular oedema: Clinical insights on the evolving role of corticosteroids 30/10/2025
Diagnosis and treatment of patients with Lennox–Gastaut syndrome 23/10/2025
Updates in hypertrophic cardiomyopathy care: Bridging the current treatment gaps with emerging novel therapies 20/10/2025
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC 20/10/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA